NLINKN1 Chip+PRIME.StudySYNCRStentrode+$75M.SeriesDPRECNLayer 7+FDA.BrkthruPARAMArgo+$20M.SeriesBBLKRKNeuroport+200.ImplantsEMTIVMN8+$45M.SeriesBKRNLFlux+Non-invasiveNRBLEHalo+Consumer.BCINEURONeuroPace+RNS.SystemCOGNICognixion+ALS.TrialFUND.YTD2026$2.8B.SectorTRIALSActive50+.ClinTrialsIMPLNTSHumans~100.Intracrtnl
Terminal/Companies/Paradromics
activeFounded 2015

Paradromics

HQ: Austin, TX, USACEO: Matt AngleHeadcount: ~30paradromics.com
Funding Summary
Total Funding
$20M+
About

Paradromics is a pre-clinical stage BCI company focused on high-bandwidth neural recording via the Connexus Direct Data Interface, targeting the highest-volume neural data acquisition of any implanted BCI in development. The company received a DARPA NESD award and has demonstrated its microwire bundle approach in large animal models. Paradromics differentiates on data volume and throughput rather than minimally invasive delivery — the company's thesis is that the bottleneck in BCI is the amount of neural data that can be captured, not the implant procedure.

Products
paradromics-connexus
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →